Search
Please see below for a list of search results.
The Human Tissue Authority (HTA) welcomes NHS Blood and Transplant’s introduction of their 3-for-1 living donor transplant scheme, launched today on World Kidney Day.
The Human Tissue Authority (HTA) welcomes the publication of the report from the Regenerative Medicine Expert Group, “Building on our own potential: a UK pathway for regenerative medicine”.
Establishments that conduct human tissue research under recognised research ethics committee approvals are exempt from being licensed for the storage of relevant material for research under the HT Act 2004.
HTA-licensed establishments in the post mortem sector are required to report incidents (HTARIs), and those in the human application and organ donation and transplantation sectors are required to report serious adverse events or reactions (SAEARs), as part of their licensing with us.
The guidance sets out that women should be given choices and that their wishes should be acted upon. Cremation and burial are the default methods of disposal.
Today the HTA published guidance aimed at professionals who work with women who have experienced a pregnancy loss or termination. The guidance sets out what is expected and how women should be involved in decision making about the sensitive handling of pregnancy remains.
On the 25 March 2015 the HTA published guidance aimed at professionals who work with women who have experienced a pregnancy loss or termination. The guidance sets out what is expected and how women should be involved in decision making about the sensitive handling of pregnancy remains.
The HTA was asked about information on its current contracts with third party suppliers
The HTA has a statutory responsibility to make decisions on all cases of bone marrow and PBSC donation where the donor is a child who lacks competence to consent or the donor is an adult lacking capacity to consent.